Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trial

Erstveröffentlichung

2020

Authors

Kapp-Schwoerer, Silke

Weber, Daniela

Corbacioglu, Andrea

Gaidzik, I, Verena

Paschka, Peter

et al.

Wissenschaftlicher Artikel

Published in

Blood ; 136 (2020), 26. - S. 3041-3050. - ISSN 0006-4971. - eISSN 1528-0020

Link to publication

https://dx.doi.org/10.1182/blood.2020005998

Institutions

UKU. Klinik für Innere Medizin III

Subject headings

[Free subject headings]: ACUTE MYELOID-LEUKEMIA | MINIMAL RESIDUAL DISEASE | POLYMERASE-CHAIN-REACTION | prognostic-significance | NPM1 | MUTATIONS | CLASSIFICATION | NUCLEOPHOSMIN | DIAGNOSIS
[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record